ID
45193
Descrizione
Principal Investigator: Todd Golub, Broad Institute, Cambridge, MA and Dana Farber Cancer Institute, Boston, MA, USA MeSH: Carcinoma, Ductal, Breast https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000369 This study combined whole exome (103 samples) and whole genome (22 samples) sequencing over a total of 108 breast tumors and matched normal DNA to identify novel mutations and translocations. Samples were subjected to paired-end Illumina sequencing with goal of 30x coverage of tumor/normal for whole genomes and 100x tumor/normal coverage for whole exomes. From these sequences, we used various computational techniques to identify somatic point mutations, insertion/deletions and structural rearrangements in these tumors. From these data, we identified new insights into the rates of background mutations in these cancers, novel recurrent mutated genes, and multiple gene rearrangements. One of these rearrangements appears to be a recurrent event in breast cancer.
collegamento
Keywords
versioni (2)
- 19/08/22 19/08/22 - Simon Heim
- 12/10/22 12/10/22 - Adrian Schulz
Titolare del copyright
Todd Golub, Broad Institute, Cambridge, MA and Dana Farber Cancer Institute, Boston, MA, USA
Caricato su
12 ottobre 2022
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
dbGaP phs000369 Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes
Subject ID, and consent groups of participants with breast cancer and involved in the "Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes" project.
- StudyEvent: SEV1
- Subject ID, and consent groups of participants with breast cancer and involved in the "Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes" project.
- Sample ID, subject ID, and sample use variables obtained from participants with breast cancer and involved in the "Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes" project.
- Subject ID, age, gender, country of subject origin, primary diagnosis, menopausal status, and tumor characteristics including expression subtype of HER 2, ER, and PR, stage, grade, and histology of tumors obtained from participants with breast cancer and involved in the Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes " project.
- Sample ID, clinical diagnosis, analyte type [DNA], sample type [tumor or normal], body site where sample was collected and obtained from participants with breast cancer and involved in the "Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes" project.
Similar models
Subject ID, and consent groups of participants with breast cancer and involved in the "Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes" project.
- StudyEvent: SEV1
- Subject ID, and consent groups of participants with breast cancer and involved in the "Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes" project.
- Sample ID, subject ID, and sample use variables obtained from participants with breast cancer and involved in the "Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes" project.
- Subject ID, age, gender, country of subject origin, primary diagnosis, menopausal status, and tumor characteristics including expression subtype of HER 2, ER, and PR, stage, grade, and histology of tumors obtained from participants with breast cancer and involved in the Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes " project.
- Sample ID, clinical diagnosis, analyte type [DNA], sample type [tumor or normal], body site where sample was collected and obtained from participants with breast cancer and involved in the "Sequence Analysis of Mutations and Translocations Across Breast Cancer Subtypes" project.
C1257890 (UMLS CUI [1,2])